BR9815775A - Anticorpos monoclonais anti-antìgeno carcinoembriÈnico (cea) humanizados de elevada afinidade - Google Patents

Anticorpos monoclonais anti-antìgeno carcinoembriÈnico (cea) humanizados de elevada afinidade

Info

Publication number
BR9815775A
BR9815775A BR9815775-2A BR9815775A BR9815775A BR 9815775 A BR9815775 A BR 9815775A BR 9815775 A BR9815775 A BR 9815775A BR 9815775 A BR9815775 A BR 9815775A
Authority
BR
Brazil
Prior art keywords
cea
high affinity
monoclonal antibodies
carcinoembryonic
humanized
Prior art date
Application number
BR9815775-2A
Other languages
English (en)
Inventor
William Henry Kerr Anderson
Philip R Tempest
Frank J Carr
William J Harris
Kathryn Armour
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Priority to BR9815775-2A priority Critical patent/BR9815775A/pt
Priority claimed from PCT/US1998/003680 external-priority patent/WO1999043817A1/en
Publication of BR9815775A publication Critical patent/BR9815775A/pt

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Patente de Invenção: <B>''ANTICORPOS MONOCLONAIS ANTI-ANTìGENO CARCINOEMBRIÈNICO (CEA) HUMANIZADOS DE ELEVADA AFINIDADE''<D>. Novos anticorpos monoclonais humanizados, fragmentos ou derivados destes que especificamente ligam antígeno carcinoembriónico (CEA) são fornecidos, bem como métodos para sua preparação. Estes anticorpos humanizados são úteis no tratamento de cânceres que expressam CEA, bem como para os propósitos de diagnóstico, por exemplo, imagem in vivo de tumores ou células cancerígenas que expressam CEA.
BR9815775-2A 1998-02-25 1998-02-25 Anticorpos monoclonais anti-antìgeno carcinoembriÈnico (cea) humanizados de elevada afinidade BR9815775A (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR9815775-2A BR9815775A (pt) 1998-02-25 1998-02-25 Anticorpos monoclonais anti-antìgeno carcinoembriÈnico (cea) humanizados de elevada afinidade

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BR9815775-2A BR9815775A (pt) 1998-02-25 1998-02-25 Anticorpos monoclonais anti-antìgeno carcinoembriÈnico (cea) humanizados de elevada afinidade
PCT/US1998/003680 WO1999043817A1 (en) 1998-02-25 1998-02-25 High affinity humanized anti-cea monoclonal antibodies

Publications (1)

Publication Number Publication Date
BR9815775A true BR9815775A (pt) 2000-11-21

Family

ID=25665184

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9815775-2A BR9815775A (pt) 1998-02-25 1998-02-25 Anticorpos monoclonais anti-antìgeno carcinoembriÈnico (cea) humanizados de elevada afinidade

Country Status (1)

Country Link
BR (1) BR9815775A (pt)

Similar Documents

Publication Publication Date Title
NZ512247A (en) Compositions and methods for therapy and diagnosis of ovarian cancer
HUP9901562A2 (hu) Anti-CEA monoklonális antitestek, az ezeket tartalmazó konjugátumok és ezek felhasználása antitest irányított enzimes előgyógyszer terápiában
PL366575A1 (pl) Kompozycje oraz sposoby leczenia i diagnozowania raka jajnika
DE69734109D1 (de) Humanisierung von anti-carcinoembryonalen Antigen anti-idiotypischen Antikörper und dessen Verwendung als Tumorvakzin und zur Markierung
WO1999004265A8 (en) Cancer associated nucleic acids and polypeptides
CY1113326T1 (el) Ανθρωπινα αντισωματα τα οποια δεσμευουν ανθρωπινη il-12 και μεθοδοι παραγωγης τους
ATE229073T1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
BG101024A (bg) Моноклонално антитяло срещу сd44v6
WO2005055936A3 (en) Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells
BRPI0414513A (pt) kid3 e anticorpos de kid3 que se ligam a ele
DE69724428D1 (de) Humanisierte antikörper die an das gleiche antigen wie antikörper nr-lu-13 binden und deren verwendung in &#34;pretargeting&#34; verfahren
AU2829889A (en) Sf-25 colon adenocarcinoma antigen, and antibodies which recognize this antigen
WO2003064593A3 (en) Antigen panels and methods of using the same
ATE248189T1 (de) Antikörper gegen vasp (vasodilator-stimulated phosphoprotein), hybridomzellen für deren gewinnung, und deren verwendung
DE69126038D1 (de) Diagnose von krebs-metastasen durch das mts-1 gen
NO20004250D0 (no) Humaniserte anti-TAG-72 monoklonale antistoffer med høy affinitet
NO20004251L (no) Humaniserte anti-CEA monoklonale antistoffer med høy affinitet
UY26266A1 (es) Antigeno asociado con tumores (r11) ley 17164
EA200601405A1 (ru) Гуманизированное антитело
EA200600995A1 (ru) Молекулы, ингибирующие ангиогенез, и их применение в лечении и диагностике рака
WO2004094612A3 (en) Cancer specific monoclonal antibodies
WO2004101762A3 (en) Detection and treatment of cancers of the colon
WO2003024302A3 (en) Detection and treatment of cancers of breast
DE69942637D1 (de) Zusammensetzungen und verfahren für die therapie und diagnose von ovariumkrebs
WO2003024304A3 (en) Detection and treatment of cancers of the liver

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 7,8 E 9A ANUIDADES

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1910 DE 14/08/2007.

B15K Others concerning applications: alteration of classification

Ipc: C07K 16/30 (2006.01), C07K 16/46 (2006.01), C12N 1